25 May 2013
Keywords: phase, ii, results, bb, lexipafant, british, biotech
Article | 18 September 1995
British Biotech has completed its Phase II trial of intravenous
lexipafant in patients with acute pancreatitis, and has revealed that
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 September 1995
24 May 2013
© 2013 thepharmaletter.com